0 XP   0   0   0

Merck & Co. Inc










Financial Health of Merck & Co. Inc




Comparing to competitors in the Other industry




  Industry Rankings  


Merck & Co. Inc
Buy, Hold or Sell?

Should you buy, hold or sell Merck & Co. Inc?

I guess you are interested in Merck & Co. Inc. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

Let's analyse Merck & Co. Inc

Let's start. I'm going to help you getting a better view of Merck & Co. Inc. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

  1. Company's Financial Health
    A deep dive into the books. How are the numbers doing? Is Merck & Co. Inc even making a profit? Is the company skyrocketing? Or is it sinking like the Titanic. The trend is your friend.
  2. Market Valuation
    Finally, you now have an insight of how Merck & Co. Inc is doing in the market. If the company is worth buying. The latest step is to find out how other investors value Merck & Co. Inc. The closing price on 2022-12-07 was €104.00 per share. Is the company over- or underpriced?
  3. Key Performance Indicators
    A total overlook on how the company is doing. Based on the (trends in) the key performance indicators.
Merck & Co. Inc Daily Candlestick Chart

Summary

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge profit.
Using its assets, the company is less efficient in making profit.
Using its investors money, the company is less efficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is less efficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is just able to pay all its short-term debts.
The company is just not able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is able to pay all its debts by selling its assets.
The company is just able to pay all its debts with equity.

1.1. Profitability of Merck & Co. Inc.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Merck & Co. Inc earns for each €1 of revenue.

  • Above 10% is considered healthy but always compare Merck & Co. Inc to the Other industry mean.
  • A Net Profit Margin of 27.0% means that €0.27 for each €1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Merck & Co. Inc:

  • The MRQ is 27.0%. The company is making a huge profit. +2
  • The TTM is 27.3%. The company is making a huge profit. +2
Trends
Current periodCompared to+/- 
MRQ27.0%TTM27.3%-0.3%
TTM27.3%YOY14.5%+12.8%
TTM27.3%5Y19.6%+7.7%
5Y19.6%10Y18.3%+1.3%
Compared to industry (Other)
PeriodCompanyIndustry (mean)+/- 
MRQ27.0%8.2%+18.8%
TTM27.3%7.4%+19.9%
YOY14.5%7.3%+7.2%
5Y19.6%6.7%+12.9%
10Y18.3%6.6%+11.7%
1.1.2. Return on Assets

Shows how efficient Merck & Co. Inc is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Merck & Co. Inc to the Other industry mean.
  • 3.7% Return on Assets means that Merck & Co. Inc generated €0.04 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Merck & Co. Inc:

  • The MRQ is 3.7%. Using its assets, the company is less efficient in making profit.
  • The TTM is 3.8%. Using its assets, the company is less efficient in making profit.
Trends
Current periodCompared to+/- 
MRQ3.7%TTM3.8%-0.1%
TTM3.8%YOY2.0%+1.8%
TTM3.8%5Y2.7%+1.1%
5Y2.7%10Y2.4%+0.2%
Compared to industry (Other)
PeriodCompanyIndustry (mean)+/- 
MRQ3.7%1.0%+2.7%
TTM3.8%1.0%+2.8%
YOY2.0%0.9%+1.1%
5Y2.7%0.9%+1.8%
10Y2.4%0.9%+1.5%
1.1.3. Return on Equity

Shows how efficient Merck & Co. Inc is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Merck & Co. Inc to the Other industry mean.
  • 9.1% Return on Equity means Merck & Co. Inc generated €0.09 for each €1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Merck & Co. Inc:

  • The MRQ is 9.1%. Using its investors money, the company is less efficient in making profit.
  • The TTM is 9.8%. Using its investors money, the company is less efficient in making profit.
Trends
Current periodCompared to+/- 
MRQ9.1%TTM9.8%-0.7%
TTM9.8%YOY5.2%+4.6%
TTM9.8%5Y7.9%+2.0%
5Y7.9%10Y7.0%+0.8%
Compared to industry (Other)
PeriodCompanyIndustry (mean)+/- 
MRQ9.1%3.1%+6.0%
TTM9.8%2.9%+6.9%
YOY5.2%2.6%+2.6%
5Y7.9%2.4%+5.5%
10Y7.0%2.4%+4.6%

1.2. Operating Efficiency of Merck & Co. Inc.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Merck & Co. Inc is operating .

  • Measures how much profit Merck & Co. Inc makes for each €1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Merck & Co. Inc to the Other industry mean.
  • An Operating Margin of 0.0% means the company generated €0.00  for each €1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Merck & Co. Inc:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY-1.8%+1.8%
TTM-5Y18.2%-18.2%
5Y18.2%10Y18.4%-0.2%
Compared to industry (Other)
PeriodCompanyIndustry (mean)+/- 
MRQ-17.1%-17.1%
TTM-9.1%-9.1%
YOY-1.8%9.2%-11.0%
5Y18.2%8.5%+9.7%
10Y18.4%8.5%+9.9%
1.2.2. Operating Ratio

Measures how efficient Merck & Co. Inc is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Other industry mean).
  • An Operation Ratio of 0.94 means that the operating costs are €0.94 for each €1 in net sales.

Let's take a look of the Operating Ratio trends of Merck & Co. Inc:

  • The MRQ is 0.942. The company is less efficient in keeping operating costs low.
  • The TTM is 0.979. The company is less efficient in keeping operating costs low.
Trends
Current periodCompared to+/- 
MRQ0.942TTM0.979-0.037
TTM0.979YOY1.160-0.181
TTM0.9795Y1.052-0.073
5Y1.05210Y1.062-0.010
Compared to industry (Other)
PeriodCompanyIndustry (mean)+/- 
MRQ0.9421.218-0.276
TTM0.9791.189-0.210
YOY1.1601.203-0.043
5Y1.0521.289-0.237
10Y1.0621.314-0.252

1.3. Liquidity of Merck & Co. Inc.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Merck & Co. Inc is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Other industry mean).
  • A Current Ratio of 1.39 means the company has €1.39 in assets for each €1 in short-term debts.

Let's take a look of the Current Ratio trends of Merck & Co. Inc:

  • The MRQ is 1.386. The company is just able to pay all its short-term debts.
  • The TTM is 1.350. The company is just able to pay all its short-term debts.
Trends
Current periodCompared to+/- 
MRQ1.386TTM1.350+0.036
TTM1.350YOY1.164+0.187
TTM1.3505Y1.168+0.182
5Y1.16810Y1.225-0.057
Compared to industry (Other)
PeriodCompanyIndustry (mean)+/- 
MRQ1.3861.491-0.105
TTM1.3501.465-0.115
YOY1.1641.475-0.311
5Y1.1681.299-0.131
10Y1.2251.286-0.061
1.3.2. Quick Ratio

Measures if Merck & Co. Inc is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Merck & Co. Inc to the Other industry mean.
  • A Quick Ratio of 0.44 means the company can pay off €0.44 for each €1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Merck & Co. Inc:

  • The MRQ is 0.436. The company is just not able to pay all its short-term debts with the most liquid assets. -1
  • The TTM is 0.426. The company is just not able to pay all its short-term debts with the most liquid assets. -1
Trends
Current periodCompared to+/- 
MRQ0.436TTM0.426+0.009
TTM0.426YOY0.330+0.097
TTM0.4265Y0.355+0.072
5Y0.35510Y0.391-0.036
Compared to industry (Other)
PeriodCompanyIndustry (mean)+/- 
MRQ0.4360.612-0.176
TTM0.4260.602-0.176
YOY0.3300.600-0.270
5Y0.3550.563-0.208
10Y0.3910.552-0.161

1.4. Solvency of Merck & Co. Inc.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Merck & Co. Inc assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Merck & Co. Inc to Other industry mean.
  • A Debt to Asset Ratio of 0.60 means that Merck & Co. Inc assets are financed with 59.6% credit (debt) and the remaining percentage (100% - 59.6%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Merck & Co. Inc:

  • The MRQ is 0.596. The company is able to pay all its debts by selling its assets. +1
  • The TTM is 0.617. The company is able to pay all its debts by selling its assets. +1
Trends
Current periodCompared to+/- 
MRQ0.596TTM0.617-0.021
TTM0.617YOY0.668-0.052
TTM0.6175Y0.658-0.041
5Y0.65810Y0.644+0.013
Compared to industry (Other)
PeriodCompanyIndustry (mean)+/- 
MRQ0.5960.562+0.034
TTM0.6170.583+0.034
YOY0.6680.586+0.082
5Y0.6580.583+0.075
10Y0.6440.576+0.068
1.4.2. Debt to Equity Ratio

Measures if Merck & Co. Inc is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Merck & Co. Inc to the Other industry mean.
  • A Debt to Equity ratio of 147.5% means that company has €1.47 debt for each €1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Merck & Co. Inc:

  • The MRQ is 1.475. The company is able to pay all its debts with equity. +1
  • The TTM is 1.616. The company is just able to pay all its debts with equity.
Trends
Current periodCompared to+/- 
MRQ1.475TTM1.616-0.141
TTM1.616YOY2.078-0.462
TTM1.6165Y1.968-0.351
5Y1.96810Y1.870+0.097
Compared to industry (Other)
PeriodCompanyIndustry (mean)+/- 
MRQ1.4751.244+0.231
TTM1.6161.337+0.279
YOY2.0781.370+0.708
5Y1.9681.439+0.529
10Y1.8701.455+0.415

2. Market Valuation of Merck & Co. Inc

2. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every €1 in earnings Merck & Co. Inc generates.

  • Above 15 is considered overpriced but always compare Merck & Co. Inc to the Other industry mean.
  • A PE ratio of 59.08 means the investor is paying €59.08 for every €1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Merck & Co. Inc:

  • The EOD is 70.226. Neutral. Compare to industry.
  • The MRQ is 59.084. Good. +1
  • The TTM is 51.041. Good. +1
Trends
Current periodCompared to+/- 
EOD70.226MRQ59.084+11.142
MRQ59.084TTM51.041+8.043
TTM51.041YOY30.905+20.135
TTM51.0415Y36.291+14.750
5Y36.29110Y30.243+6.049
Compared to industry (Other)
PeriodCompanyIndustry (mean)+/- 
EOD70.22636.308+33.918
MRQ59.08438.458+20.626
TTM51.04144.588+6.453
YOY30.90548.072-17.167
5Y36.29140.090-3.799
10Y30.24341.443-11.200
2.2. Price Earnings to Growth Ratio

Measures the predicted future growth of Merck & Co. Inc.

  • Lower is better.
  • A PEG ratio of 1 means the market price of the stock and the expected future earnings are on par.

Let's take a look of the Price Earnings to Growth Ratio trends of Merck & Co. Inc:

  • The MRQ is -622.671. Very Bad. -2
  • The TTM is -161.482. Very Bad. -2
Trends
Current periodCompared to+/- 
MRQ-622.671TTM-161.482-461.189
TTM-161.482YOY3.792-165.274
TTM-161.4825Y-348.878+187.396
5Y-348.87810Y-348.8780.000
Compared to industry (Other)
PeriodCompanyIndustry (mean)+/- 
MRQ-622.6710.154-622.825
TTM-161.4820.050-161.532
YOY3.7920.186+3.606
5Y-348.8780.158-349.036
10Y-348.8780.155-349.033

2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Merck & Co. Inc is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Other industry mean).
  • A PB ratio of 5.38 means the investor is paying €5.38 for each €1 in book value.

Let's take a look of the Price to Book Ratio trends of Merck & Co. Inc:

  • The EOD is 6.394. Seems overpriced? -1
  • The MRQ is 5.379. Seems overpriced? -1
  • The TTM is 4.980. Neutral. Compare to industry.
Trends
Current periodCompared to+/- 
EOD6.394MRQ5.379+1.014
MRQ5.379TTM4.980+0.400
TTM4.980YOY5.707-0.727
TTM4.9805Y4.362+0.617
5Y4.36210Y3.635+0.727
Compared to industry (Other)
PeriodCompanyIndustry (mean)+/- 
EOD6.3941.411+4.983
MRQ5.3791.419+3.960
TTM4.9801.575+3.405
YOY5.7071.352+4.355
5Y4.3621.288+3.074
10Y3.6351.330+2.305
2. Total Gains per Share

3. Summary

3.1. Key Performance Indicators

The key performance indicators of Merck & Co. Inc compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share--0.8590.919-7%0.626+37%1.479-42%1.479-42%
Book Value Growth--0.0060.013-54%-0.008+230%-0.056+1060%-0.058+1095%
Book Value Per Share--16.26615.357+6%11.440+42%8.861+84%7.384+120%
Book Value Per Share Growth--0.0530.060-12%0.042+25%0.133-60%0.133-60%
Current Ratio--1.3861.350+3%1.164+19%1.168+19%1.225+13%
Debt To Asset Ratio--0.5960.617-3%0.668-11%0.658-9%0.644-8%
Debt To Equity Ratio--1.4751.616-9%2.078-29%1.968-25%1.870-21%
Dividend Per Share--0.6650.646+3%0.612+9%0.607+10%0.607+10%
Dividend Per Share Growth--0.0120.022-44%0.016-24%0.022-45%0.022-45%
Eps--1.4811.506-2%0.677+119%0.770+92%0.642+131%
Eps Growth---0.095-0.061-36%-0.285+201%-0.013-86%-0.013-86%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%1.0000%
Net Profit Margin--0.2700.273-1%0.145+87%0.196+38%0.183+48%
Operating Margin----0%-0.0180%0.182-100%0.184-100%
Operating Ratio--0.9420.979-4%1.160-19%1.052-10%1.062-11%
Pb Ratio6.394+16%5.3794.980+8%5.707-6%4.362+23%3.635+48%
Pe Ratio70.226+16%59.08451.041+16%30.905+91%36.291+63%30.243+95%
Peg Ratio---622.671-161.482-74%3.792-16522%-348.878-44%-348.878-44%
Price Per Share104.000+16%87.50076.677+14%64.117+36%69.419+26%67.279+30%
Price To Total Gains Ratio68.274+16%57.44249.095+17%10.513+446%36.843+56%36.843+56%
Profit Growth---14.919-11.470-23%-32.595+118%-11.293-24%-229.854+1441%
Quick Ratio--0.4360.426+2%0.330+32%0.355+23%0.391+11%
Return On Assets--0.0370.038-2%0.020+89%0.027+37%0.024+51%
Return On Equity--0.0910.098-7%0.052+74%0.079+16%0.070+30%
Revenue Growth---0.146-0.021-86%-0.042-71%-0.034-76%-0.031-79%
Total Gains Per Share--1.5231.566-3%1.237+23%2.085-27%2.085-27%
Total Gains Per Share Growth---0.094-0.018-81%-0.226+140%-1.320+1305%-1.320+1305%
Usd Book Value--43330212210.56040854181031.253+6%30432076993.120+42%31765161905.899+36%33382258721.582+30%
Usd Book Value Change Per Share--0.9030.967-7%0.658+37%1.555-42%1.555-42%
Usd Book Value Per Share--17.10516.149+6%12.030+42%9.319+84%7.765+120%
Usd Dividend Per Share--0.6990.680+3%0.643+9%0.638+10%0.638+10%
Usd Eps--1.5571.583-2%0.712+119%0.810+92%0.675+131%
Usd Price Per Share109.366+16%92.01580.633+14%67.425+36%73.001+26%70.751+30%
Usd Profit--3945111892.4804005128807.680-1%1799757244.560+119%2487118520.597+59%2273629633.831+74%
Usd Revenue--14597114058.56014675802902.933-1%12291214162.480+19%12433854406.336+17%12096042694.169+21%
Usd Total Gains Per Share--1.6021.646-3%1.301+23%2.193-27%2.193-27%
 EOD+2 -3MRQTTM+13 -21YOY+30 -45Y+22 -1310Y+23 -12

3.2. Fundamental Score

Let's check the fundamental score of Merck & Co. Inc based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-1570.226
Price to Book Ratio (EOD)Between0-16.394
Net Profit Margin (MRQ)Greater than00.270
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than10.436
Current Ratio (MRQ)Greater than11.386
Debt to Asset Ratio (MRQ)Less than10.596
Debt to Equity Ratio (MRQ)Less than11.475
Return on Equity (MRQ)Greater than0.150.091
Return on Assets (MRQ)Greater than0.050.037
Total3/10 (30.0%)

3.3. Technical Score

Let's check the technical score of Merck & Co. Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
OpenGreater thanClose103.800
Total0/1 (0.0%)



Latest Balance Sheet

Balance Sheet of 2022-06-30. Currency in USD. All numbers in thousands.

Summary
Total Assets107,095,000
Total Liabilities63,777,000
Total Stockholder Equity43,243,000
 As reported
Total Liabilities 63,777,000
Total Stockholder Equity+ 43,243,000
Total Assets = 107,095,000

Assets

Total Assets107,095,000
Total Current Assets32,116,000
Long-term Assets32,116,000
Total Current Assets
Cash And Cash Equivalents 9,675,000
Short-term Investments 453,000
Net Receivables 9,643,000
Inventory 5,535,000
Other Current Assets 6,810,000
Total Current Assets  (as reported)32,116,000
Total Current Assets  (calculated)32,116,000
+/-0
Long-term Assets
Goodwill 21,213,000
Long Term Investments 238,000
Intangible Assets 22,497,000
Long-term Assets Other 10,972,000
Long-term Assets  (as reported)74,979,000
Long-term Assets  (calculated)54,920,000
+/- 20,059,000

Liabilities & Shareholders' Equity

Total Current Liabilities23,168,000
Long-term Liabilities40,609,000
Total Stockholder Equity43,243,000
Total Current Liabilities
Short Long Term Debt 2,979,000
Accounts payable 3,482,000
Total Current Liabilities  (as reported)23,168,000
Total Current Liabilities  (calculated)6,461,000
+/- 16,707,000
Long-term Liabilities
Long term Debt 28,684,000
Long-term Liabilities Other 8,951,000
Long-term Liabilities  (as reported)40,609,000
Long-term Liabilities  (calculated)37,635,000
+/- 2,974,000
Total Stockholder Equity
Retained Earnings 58,437,000
Total Stockholder Equity (as reported)43,243,000
Total Stockholder Equity (calculated)58,437,000
+/- 15,194,000
Other
Capital Stock1,788,000
Common Stock Shares Outstanding 2,533,209
Net Debt 21,988,000
Net Invested Capital 74,906,000
Net Working Capital 8,948,000



Balance Sheet

Currency in USD. All numbers in thousands.

 Trend2022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312017-12-312017-09-302017-06-302017-03-31
> Total Assets 
96,561,000
92,804,000
91,676,000
0
82,354,000
83,965,000
83,331,000
84,397,000
84,913,000
90,615,000
89,800,000
91,588,000
90,847,000
90,688,000
93,494,000
105,694,000
106,668,000
107,095,000
107,095,000106,668,000105,694,00093,494,00090,688,00090,847,00091,588,00089,800,00090,615,00084,913,00084,397,00083,331,00083,965,00082,354,000091,676,00092,804,00096,561,000
   > Total Current Assets 
31,530,000
28,167,000
27,919,000
0
25,351,000
24,298,000
26,142,000
27,483,000
26,174,000
29,343,000
26,577,000
27,764,000
26,909,000
28,665,000
31,058,000
30,266,000
31,184,000
32,116,000
32,116,00031,184,00030,266,00031,058,00028,665,00026,909,00027,764,00026,577,00029,343,00026,174,00027,483,00026,142,00024,298,00025,351,000027,919,00028,167,00031,530,000
       Cash And Cash Equivalents 
11,708,000
7,786,000
7,901,000
0
8,076,000
6,659,000
7,869,000
9,676,000
7,425,000
11,103,000
7,356,000
8,062,000
6,981,000
8,575,000
10,016,000
8,096,000
8,556,000
9,675,000
9,675,0008,556,0008,096,00010,016,0008,575,0006,981,0008,062,0007,356,00011,103,0007,425,0009,676,0007,869,0006,659,0008,076,00007,901,0007,786,00011,708,000
       Short-term Investments 
3,541,000
4,181,000
3,294,000
0
722,000
446,000
149,000
774,000
7,000
0
0
0
0
0
0
0
372,000
453,000
453,000372,00000000007,000774,000149,000446,000722,00003,294,0004,181,0003,541,000
       Net Receivables 
7,066,000
7,439,000
7,671,000
0
7,608,000
7,964,000
8,442,000
6,778,000
8,182,000
7,577,000
8,422,000
7,851,000
8,235,000
7,843,000
8,571,000
9,230,000
9,828,000
9,643,000
9,643,0009,828,0009,230,0008,571,0007,843,0008,235,0007,851,0008,422,0007,577,0008,182,0006,778,0008,442,0007,964,0007,608,00007,671,0007,439,0007,066,000
       Inventory 
5,146,000
5,407,000
5,263,000
0
5,712,000
5,847,000
7,370,000
5,978,000
7,476,000
7,977,000
8,209,000
6,310,000
8,577,000
7,911,000
7,976,000
5,953,000
5,774,000
5,535,000
5,535,0005,774,0005,953,0007,976,0007,911,0008,577,0006,310,0008,209,0007,977,0007,476,0005,978,0007,370,0005,847,0005,712,00005,263,0005,407,0005,146,000
       Other Current Assets 
4,069,000
3,354,000
3,790,000
0
3,233,000
3,382,000
2,312,000
4,277,000
3,084,000
2,686,000
2,590,000
5,541,000
3,116,000
4,336,000
4,495,000
6,987,000
6,654,000
6,810,000
6,810,0006,654,0006,987,0004,495,0004,336,0003,116,0005,541,0002,590,0002,686,0003,084,0004,277,0002,312,0003,382,0003,233,00003,790,0003,354,0004,069,000
   > Long-term Assets 
0
0
0
0
57,003,000
59,667,000
57,189,000
56,914,000
58,739,000
61,272,000
63,223,000
63,824,000
63,938,000
62,023,000
62,436,000
75,428,000
75,484,000
74,979,000
74,979,00075,484,00075,428,00062,436,00062,023,00063,938,00063,824,00063,223,00061,272,00058,739,00056,914,00057,189,00059,667,00057,003,0000000
       Property Plant Equipment 
12,042,000
12,094,000
12,189,000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
00000000000000012,189,00012,094,00012,042,000
       Goodwill 
18,358,000
18,358,000
18,340,000
0
18,170,000
19,490,000
19,480,000
19,425,000
19,767,000
20,067,000
20,248,000
20,238,000
20,212,000
18,873,000
18,862,000
21,264,000
21,258,000
21,213,000
21,213,00021,258,00021,264,00018,862,00018,873,00020,212,00020,238,00020,248,00020,067,00019,767,00019,425,00019,480,00019,490,00018,170,000018,340,00018,358,00018,358,000
       Long Term Investments 
11,907,000
12,159,000
12,221,000
0
5,621,000
3,779,000
2,111,000
1,469,000
555,000
1,251,000
1,372,000
785,000
544,000
411,000
435,000
370,000
316,000
238,000
238,000316,000370,000435,000411,000544,000785,0001,372,0001,251,000555,0001,469,0002,111,0003,779,0005,621,000012,221,00012,159,00011,907,000
       Intangible Assets 
16,863,000
16,119,000
15,138,000
0
10,999,000
13,381,000
12,307,000
14,196,000
16,096,000
16,566,000
16,677,000
14,604,000
14,401,000
13,622,000
13,384,000
22,933,000
23,022,000
22,497,000
22,497,00023,022,00022,933,00013,384,00013,622,00014,401,00014,604,00016,677,00016,566,00016,096,00014,196,00012,307,00013,381,00010,999,000015,138,00016,119,00016,863,000
       Long-term Assets Other 
0
0
0
0
8,707,000
9,155,000
9,004,000
6,771,000
7,052,000
7,599,000
8,007,000
10,211,000
10,486,000
11,053,000
11,190,000
11,582,000
11,141,000
10,972,000
10,972,00011,141,00011,582,00011,190,00011,053,00010,486,00010,211,0008,007,0007,599,0007,052,0006,771,0009,004,0009,155,0008,707,0000000
> Total Liabilities 
56,473,000
53,092,000
53,177,000
0
54,684,000
56,228,000
56,406,000
58,396,000
58,613,000
62,871,000
60,530,000
66,184,000
63,808,000
57,300,000
57,631,000
67,437,000
65,715,000
63,777,000
63,777,00065,715,00067,437,00057,631,00057,300,00063,808,00066,184,00060,530,00062,871,00058,613,00058,396,00056,406,00056,228,00054,684,000053,177,00053,092,00056,473,000
   > Total Current Liabilities 
19,823,000
18,758,000
19,467,000
0
18,543,000
20,085,000
20,684,000
22,220,000
23,483,000
22,178,000
20,405,000
27,327,000
26,361,000
21,906,000
23,728,000
23,872,000
22,316,000
23,168,000
23,168,00022,316,00023,872,00023,728,00021,906,00026,361,00027,327,00020,405,00022,178,00023,483,00022,220,00020,684,00020,085,00018,543,000019,467,00018,758,00019,823,000
       Short-term Debt 
28,509,000
24,910,000
27,021,000
27,021,000
3,175,000
3,816,000
3,411,000
3,610,000
0
0
0
0
0
0
0
0
0
0
00000000003,610,0003,411,0003,816,0003,175,00027,021,00027,021,00024,910,00028,509,000
       Short Long Term Debt 
28,509,000
24,910,000
27,021,000
27,021,000
3,175,000
3,816,000
3,411,000
3,610,000
6,361,000
4,718,000
2,420,000
6,431,000
7,251,000
2,488,000
3,534,000
2,412,000
1,208,000
2,979,000
2,979,0001,208,0002,412,0003,534,0002,488,0007,251,0006,431,0002,420,0004,718,0006,361,0003,610,0003,411,0003,816,0003,175,00027,021,00027,021,00024,910,00028,509,000
       Accounts payable 
2,484,000
2,934,000
2,620,000
0
3,018,000
3,142,000
3,198,000
3,738,000
3,572,000
3,448,000
3,744,000
4,594,000
4,034,000
3,897,000
3,366,000
4,609,000
3,715,000
3,482,000
3,482,0003,715,0004,609,0003,366,0003,897,0004,034,0004,594,0003,744,0003,448,0003,572,0003,738,0003,198,0003,142,0003,018,00002,620,0002,934,0002,484,000
       Other Current Liabilities 
3,976,000
3,523,000
1,906,000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0000000000000001,906,0003,523,0003,976,000
   > Long-term Liabilities 
0
0
0
0
36,141,000
36,143,000
35,722,000
36,176,000
35,130,000
40,693,000
40,125,000
38,857,000
37,447,000
35,394,000
33,903,000
43,565,000
43,399,000
40,609,000
40,609,00043,399,00043,565,00033,903,00035,394,00037,447,00038,857,00040,125,00040,693,00035,130,00036,176,00035,722,00036,143,00036,141,0000000
       Long-term Liabilities Other 
0
0
0
0
11,585,000
11,283,000
11,085,000
11,970,000
11,550,000
12,446,000
12,027,000
12,482,000
12,241,000
9,872,000
9,469,000
9,434,000
9,742,000
8,951,000
8,951,0009,742,0009,434,0009,469,0009,872,00012,241,00012,482,00012,027,00012,446,00011,550,00011,970,00011,085,00011,283,00011,585,0000000
> Total Stockholder Equity
39,837,000
39,463,000
38,248,000
38,248,000
27,539,000
27,635,000
26,838,000
25,907,000
26,205,000
27,642,000
29,186,000
25,317,000
26,945,000
33,294,000
35,794,000
38,184,000
40,883,000
43,243,000
43,243,00040,883,00038,184,00035,794,00033,294,00026,945,00025,317,00029,186,00027,642,00026,205,00025,907,00026,838,00027,635,00027,539,00038,248,00038,248,00039,463,00039,837,000
   Common Stock
1,788,000
1,788,000
1,788,000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0000000000000001,788,0001,788,0001,788,000
   Retained Earnings 
44,387,000
45,046,000
43,701,000
0
44,065,000
45,295,000
45,804,000
46,602,000
48,272,000
49,724,000
51,107,000
47,362,000
48,888,000
48,777,000
51,691,000
53,696,000
56,252,000
58,437,000
58,437,00056,252,00053,696,00051,691,00048,777,00048,888,00047,362,00051,107,00049,724,00048,272,00046,602,00045,804,00045,295,00044,065,000043,701,00045,046,00044,387,000
   Capital Surplus 000000000000000000
   Treasury Stock000000000000000000
   Other Stockholders Equity 000000000000000-4,945,000-5,094,000-5,080,000



Balance Sheet

Currency in USD. All numbers in thousands.




Cash Flow

Currency in USD. All numbers in thousands.




Income Statement

Currency in USD. All numbers in thousands.


Latest Income Statement (annual, 2021-12-31)

Gross Profit (+$)
totalRevenue48,704,000
Cost of Revenue-13,626,000
Gross Profit35,078,00035,078,000
 
Operating Income (+$)
Gross Profit35,078,000
Operating Expense-35,505,000
Operating Income13,199,000-427,000
 
Operating Expense (+$)
Research Development12,245,000
Selling General Administrative9,634,000
Selling And Marketing Expenses-
Operating Expense35,505,00021,879,000
 
Net Interest Income (+$)
Interest Income36,000
Interest Expense-806,000
Net Interest Income-770,000-770,000
 
Pretax Income (+$)
Operating Income13,199,000
Net Interest Income-770,000
Other Non-Operating Income Expenses-
Income Before Tax (EBT)13,879,00011,749,000
EBIT - interestExpense = -806,000
13,049,000
13,855,000
Interest Expense806,000
Earnings Before Interest and Taxes (ebit)-14,685,000
Earnings Before Interest and Taxes (ebitda)17,899,000
 
After tax Income (+$)
Income Before Tax13,879,000
Tax Provision-1,521,000
Net Income From Continuing Ops12,358,00012,358,000
Net Income13,049,000
Net Income Applicable To Common Shares-
 
Non-recurring Events
Discontinued Operations-
Extraordinary Items-
Effect of Accounting Charges-
Other Items-
Non Recurring-
Other Operating Expenses-
Total Other Income/Expenses Net1,450,000770,000
 

Comments

Join the conversation.

Leave a comment

Stay informed with my latest content.

Subscribe to my newsletter and receive an email as soon as I add content to PenkeTrading.com.


By clicking Register, you agree to the General Terms and Conditions.
Penke's Market Notifications
0QN1.LSE
3 minutes ago

I found you a Oversold RSI (Relative Strength Index) on the daily chart of 0QN1.LSE.

0QN1.LSE Daily Candlestick Chart
0NTM.LSE
6 minutes ago

I found you a Golden Cross on the daily chart of 0NTM.LSE.

0NTM.LSE Daily Candlestick Chart
0NOF.LSE
6 minutes ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of 0NOF.LSE.

0NOF.LSE Daily Candlestick Chart
0MKW.LSE
8 minutes ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of 0MKW.LSE.

0MKW.LSE Daily Candlestick Chart
0H9P.LSE
12 minutes ago

I found you a Oversold RSI (Relative Strength Index) on the daily chart of 0H9P.LSE.

0H9P.LSE Daily Candlestick Chart
0DPU.LSE
14 minutes ago

I found you a Oversold RSI (Relative Strength Index) on the daily chart of 0DPU.LSE.

0DPU.LSE Daily Candlestick Chart
JJN.NYSE ARC
29 minutes ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of JJN.NYSE ARC.

JJN.NYSE ARC Daily Candlestick Chart
JIGB.NYSE ARC
29 minutes ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of JIGB.NYSE ARC.

JIGB.NYSE ARC Daily Candlestick Chart
ILTB.NYSE ARC
30 minutes ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of ILTB.NYSE ARC.

ILTB.NYSE ARC Daily Candlestick Chart
IHDG.NYSE ARC
30 minutes ago

I found you a Oversold RSI (Relative Strength Index) on the daily chart of IHDG.NYSE ARC.

IHDG.NYSE ARC Daily Candlestick Chart
IGLB.NYSE ARC
30 minutes ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of IGLB.NYSE ARC.

IGLB.NYSE ARC Daily Candlestick Chart
HTRB.NYSE ARC
32 minutes ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of HTRB.NYSE ARC.

HTRB.NYSE ARC Daily Candlestick Chart
NMXS.PINK
35 minutes ago

I found you a Oversold RSI (Relative Strength Index) on the daily chart of NMXS.PINK.

NMXS.PINK Daily Candlestick Chart
HEWJ.NYSE ARC
35 minutes ago

I found you a Death Cross on the daily chart of HEWJ.NYSE ARC.

HEWJ.NYSE ARC Daily Candlestick Chart
SCHQ.NYSE ARC
36 minutes ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of SCHQ.NYSE ARC.

SCHQ.NYSE ARC Daily Candlestick Chart
GTO.NYSE ARC
36 minutes ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of GTO.NYSE ARC.

GTO.NYSE ARC Daily Candlestick Chart
RJDG.PINK
38 minutes ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of RJDG.PINK.

RJDG.PINK Daily Candlestick Chart
GIGB.NYSE ARC
38 minutes ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of GIGB.NYSE ARC.

GIGB.NYSE ARC Daily Candlestick Chart
BVT.LSE
39 minutes ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of BVT.LSE.

BVT.LSE Daily Candlestick Chart
TRIRF.PINK
40 minutes ago

I found you a Oversold RSI (Relative Strength Index) on the daily chart of TRIRF.PINK.

TRIRF.PINK Daily Candlestick Chart
UITB.NASDAQ
41 minutes ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of UITB.NASDAQ.

UITB.NASDAQ Daily Candlestick Chart
UNISHIRE.BSE
42 minutes ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of UNISHIRE.BSE.

UNISHIRE.BSE Daily Candlestick Chart
FTXH.NASDAQ
42 minutes ago

I found you a Golden Cross on the daily chart of FTXH.NASDAQ.

FTXH.NASDAQ Daily Candlestick Chart
FNGD.NYSE ARC
43 minutes ago

I found you a STOCH Bearish Hidden Divergence on the daily chart of FNGD.NYSE ARC.

FNGD.NYSE ARC Daily Candlestick Chart